Merck KGaA sells Allergopharma to Dermapharm
Read time: 1 mins
Published:20th Feb 2020
Merck KGaA, a leading science and technology company, signed an agreement to sell its allergy business Allergopharma to Dermapharm Holding SE . The transaction, which is expected to close by the end of the second quarter 2020, is subject to regulatory approval and satisfaction of other customary closing conditions.